Director/PDMR Shareholding

Summary by AI ^BETAClose X

Iofina plc announced that Non-Executive Director Tim Hughes purchased 20,003 ordinary shares at 50 pence per share on June 29, 2026, increasing his beneficial holding to 20,003 ordinary shares. This transaction, valued at £10,001.50, was disclosed in accordance with the UK Market Abuse Regulation.

Disclaimer*

Iofina PLC

30 June 2026

Iofina plc

("Iofina", the "Company" or the "Group")

(AIM: IOF)

Director/PDMR Shareholding

Iofina plc (AIM: IOF), specialists in the exploration and production of iodine and manufacturers of specialty chemical products, has been notified that on 29 June 2026, Tim Hughes, Non-Executive Director, purchased 20,003 ordinary shares of 1 pence each in the Company ("Ordinary Shares") at a price of 50 pence per share, increasing his beneficial holding to 20,003 Ordinary Shares.

In accordance with Article 19 of the UK Market Abuse Regulation, detailed information is set out below.

Enquiries:

Iofina plc

Dr. Tom Becker

CEO & President

Tel: +44 (0)20 3006 3135

Nomad & Broker:

Canaccord Genuity Limited

Henry Fitzgerald-O'Connor/Harry Rees

Tel: +44 (0)20 7523 8000

Financial PR and Media Contact:

Yellow Jersey PR Limited

Charles Goodwin/Shivantha Thambirajah

Tel: +44 (0)7747 788 221/+44 (0)7983 521 488

About Iofina:

Iofina plc (AIM: IOF) is a vertically integrated company that specialises in the production of Iodine and the manufacturing of specialty chemical products. Iofina is the second largest producer of iodine in North America and operates the manufacturing entities Iofina Resources and Iofina Chemical.

LEI: 213800QDMFYVRJYYTQ84

ISIN: GB00B2QL5C79

Iofina Resources

Iofina Resources develops, builds, owns, and operates iodine extraction plants using Iofina's WET® IOsorb® technology. Iofina operates eight IOsorb® plants in Oklahoma and consistently uses technology and innovation to improve and expand its operations. A ninth plant is under construction in the Permian Basin.

Iofina Chemical

Iofina Chemical has manufactured high-quality halogen speciality chemicals derived from raw iodine, as well as non-iodine-based products. Iofina Chemical celebrated its 40^th anniversary in 2023 as a preeminent halogen-based specialty chemicals company.

www.iofina.com

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

Details of the person discharging managerial responsibilities/person closely associated

Name:

Tim Hughes

Reason for the notification

Position/status:

Non-Executive Director

Initial notification/Amendment:

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name:

Iofina plc

LEI:

213800QDMFYVRJYYTQ84

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument:

Identification code:

Ordinary Shares of 1 pence each

GB00B2QL5C79

Nature of the transaction:

Purchase of Ordinary Shares

Price(s) and volume(s):

Price(s)	Volume(s)
50p	20,003 Ordinary Shares

Aggregated information:

· Aggregated volume:

· Price:

N/A - single transaction

Date of the transaction:

29 June 2026

Place of the transaction:

AIM, London Stock Exchange (XLON)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END